Kamada

KMDA

Market cap $418M

7.25 USD

+0.23

3.28%

At close Updated Dec 15, 4:00 PM EST

1 day

3.28%

5 days

6.93%

1 month

5.99%

3 months

6.15%

6 months

1.4%

Year to date

14.53%

1 year

25%

5 years

11.54%

10 years

80.35%

About: Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Employees: 374

Healthcare Drug Manufacturers - Specialty & Generic